Brief: Sedana Medical's Sedaconda ACD Recommended By NICE

Sedana Medical AB (publ)

27/01/2022 07:34

Jan 27 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL'S SEDACONDA ACD RECOMMENDED BY NICE
    * NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
HAS
ISSUED POSITIVE GUIDANCERECOMMENDING SEDACONDA ACDAS A
COST-SAVING OPTION FOR DELIVERING INHALED SEDATION IN INTENSIVE
CARE AS AN ALTERNATIVE TO INTRAVENOUS SEDATION
    * SEDACONDA ACD IS RECOMMENDED AS AN OPTION FOR DELIVERING
INHALED
SEDATION IN INTENSIVE CARE IN ENGLAND AND WALES WHEN VOLATILE
ANAESTHETICS ARE BEING CONSIDERED
    * COST MODELLING SHOWS COST SAVINGS COMPARED WITH
INTRAVENOUS
SEDATION OF ALMOST £4,000 PER ADULT PATIENT

Source text for Eikon:  ID:nWkr3Lc02Z 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))